Solventum (SOLV) Income from Continuing Operations (2023 - 2026)
Solventum (SOLV) posted Income from Continuing Operations of 13000000.0 for Q1 2026, down 79.37% on a QoQ basis from 63000000.0 in Q4 2025, and down 90.51% year-over-year from 137000000.0 in Q1 2025.
Solventum (SOLV) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Solventum's Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 13000000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 90.51% year-over-year to 13000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1432000000.0 (up 278.84% YoY) and the FY2025 annual result came in at 1556000000.0, up 225.52% from the prior year.
- Income from Continuing Operations was 13000000.0 for Q1 2026 at Solventum, down from 63000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1266000000.0 in Q3 2025 and bottomed at 13000000.0 in Q1 2026.
- A 4-year average of 261000000.0 and a median of 137000000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations soared 937.7% — and 2026, when it tumbled 90.51%.
- Solventum's Income from Continuing Operations stood at 272000000.0 in 2023, then sank by 88.97% to 30000000.0 in 2024, then surged by 110.0% to 63000000.0 in 2025, then sank by 79.37% to 13000000.0 in 2026.
- Business Quant data shows SOLV's Income from Continuing Operations at 13000000.0 in Q1 2026, 63000000.0 in Q4 2025, and 1266000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 63.00 Mn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 137.00 Mn |
| Dec 31, 2024 | 30.00 Mn |
| Sep 30, 2024 | 122.00 Mn |
| Jun 30, 2024 | 89.00 Mn |
| Mar 31, 2024 | 237.00 Mn |
| Dec 31, 2023 | 272.00 Mn |
| Sep 30, 2023 | 460.00 Mn |
| Jun 30, 2023 | 321.00 Mn |
| Mar 31, 2023 | 293.00 Mn |